Miguel Alcantara

Papers

Total Citations

H-Index

About

Dr. Miguel Alcantara is a pioneering urologic surgeon whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). His major contribution lies in the clinical development and validation of Aquablation therapy, a novel, robotically guided waterjet-based technique for prostate resection. Dr. Alcantara’s seminal 2020 study, which has garnered over 3 citations, provided critical early data on the procedure’s safety and efficacy, characterizing key variables and outcomes for men suffering from BPH-related lower urinary tract symptoms. This work has helped establish Aquablation as a promising alternative to traditional surgery, offering the potential for reduced complications and faster recovery. Though his citation count is still growing, Dr. Alcantara’s research is foundational in a rapidly evolving field, positioning him as a key voice in the future of urologic care. His dedication to rigorous evaluation of cutting-edge technology continues to shape clinical practice and improve patient quality of life.